-
NEW AVENUES OR DEAD ENDS? EVALUATING PRIVATE HEALTH INSURANCE AND OUT-OF-POCKET PHARMACEUTICAL ACCESS ACROSS FIVE EUROPEAN MARKETS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF OPTIMISING POST-DISCHARGE CARE FOR CORONARY HEART DISEASE WITH TYPE 2 DIABETES
Aug 11, 2026, 17:16 PM -
TRENDS IN REGULATORY AND REIMBURSEMENT REVIEW TIMELINES FOR NEW DRUGS IN TAIWAN, 2018-2025
Aug 11, 2026, 17:16 PM -
REPRODUCIBILITY GAPS IN A PUBLISHED HERPES ZOSTER VACCINE ECONOMIC EVALUATION: A STRUCTURED RECONSTRUCTION USING A WEB-BASED HTA APPLICATION
Aug 11, 2026, 17:16 PM -
CLOSER, BUT NOT THERE YET: EVALUATING LARGE LANGUAGE MODELS (LLMS) FOR SCOPING SEARCHES IN ONCOLOGY SYSTEMATIC LITERATURE REVIEWS (SLRS)
Aug 11, 2026, 17:16 PM -
BEYOND CLINICAL OUTCOMES: A PATIENT AND FAMILY CO-CREATED VALUE FRAMEWORK TO CAPTURE THE FULL IMPACT OF CHRONIC CHILDHOOD DISEASE
Aug 11, 2026, 17:16 PM -
TOWARDS MORE TRANSPARENT DECISION MAKING AND FASTER PATIENT ACCESS: INTEGRATING UNMET MEDICAL NEED IN MARKET ACCESS FOR INNOVATIVE MEDICINES
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF EARLY IMMUNOTHERAPY AND TARGETED THERAPY FOR NSCLC IN BULGARIA
Aug 11, 2026, 17:16 PM -
DOES IRELAND NEED GENETIC TESTING? A HEALTH ECONOMICS PERSPECTIVE ON IRISH PRESCRIBING TRENDS, ADVERSE DRUG REACTIONS AND THE IMPACT OF PHARMACOGENOMIC TESTING
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF SEMAGLUTIDE LOSS-OF-EXCLUSIVITY IN TYPE 2 DIABETES IN CANADA
Aug 11, 2026, 17:16 PM -
SOCIOECONOMIC INEQUALITIES IN UNMET DENTAL CARE NEEDS IN GREECE: EVIDENCE FROM EU-SILC 2024
Aug 11, 2026, 17:16 PM -
ADDRESSING EVIDENCE GAPS THROUGH STRUCTURED EXPERT ELICITATION: INSIGHTS FROM RECENT NICE TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
EQUITY GAPS IN ACCESS TO ESSENTIAL CARDIOVASCULAR AND ANTIDIABETIC MEDICINES IN PAKISTAN: A MULTI-REGIONAL WHO/HAI SURVEY WITH MULTIVARIABLE ANALYSIS
Aug 11, 2026, 17:16 PM -
A REAL-WORLD PHARMACOECONOMIC EVALUATION OF CAMRELIZUMAB PLUS CHEMOTHERAPY FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA UNDER THE NATIONAL REIMBURSEMENT DRUG LIST NEGOTIATION POLICY IN CHINA
Aug 11, 2026, 17:16 PM -
A MEETING WITHOUT A RECORD: THE PROCEDURAL EMPTINESS OF THE PICO CLARIFICATION MEETING IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
THE ASSOCIATION BETWEEN EVENT-FREE SURVIVAL (EFS) AND OVERALL SURVIVAL (OS) IN HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) IN THE NETHERLANDS: AN OBSERVATIONAL STUDY OF ELECTRONIC HEALTH RECORDS
Aug 11, 2026, 17:16 PM -
THE IMPACT OF BREXIT ON PHARMACEUTICAL REGULATION AND APPROVAL IN THE UK
Aug 11, 2026, 17:16 PM -
IDENTIFYING PATTERNS IN LUNG CANCER HEALTH TECHNOLOGY ASSESSMENT OUTCOMES ACROSS ENGLAND AND GERMANY USING AN AI-ENABLED MARKET ACCESS INTELLIGENCE PLATFORM
Aug 11, 2026, 17:16 PM -
WORK-RELATED MUSCULOSKELETAL DISORDERS AND QUALITY OF WORK LIFE IN BAKERY WORKERS
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION (HCRU) AND COSTS OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN SWEDEN: A NATIONAL REGISTRY STUDY COMPARING PATIENTS WITH MATCHED POPULATION CONTROLS
Aug 11, 2026, 17:16 PM
